Diabetes and Other Diseases
622 articles
Jane Randel, Chair
Jane Randel is a Social Impact consultant and co-founder of Karp Randel, a consultancy designed to help corporations, foundations and individuals achieve their business and personal goals while making a positive impact on society. She is also a co-founder of NO MORE, a national initiative intended to tackle domestic violence and sexual assault while generating […]
Should Cancer Patients Get the COVID-19 Vaccine? Yes!
Should pancreatic cancer patients get the COVID-19 vaccine? According to the experts, yes, and as soon as they can.
New Study Targets Specific BRAF Mutation
One type of BRAF mutation may provide a target for treatment in pancreatic cancer patients, explains Dr. Michael Pishvaian.
Dousing Out-of-Control KRAS Signaling in Pancreatic Cancer
Rene Bernards and his team are targeting the signaling pathway of the KRAS mutation, which occurs in almost all pancreatic cancers.
Crafting a Medical Family Tree
Dr. Diane Simeone and genetic counselor Jessica Everett explain why it is important to create a medical family tree for pancreatic cancer.
For Tommy Thompson, the Commitment to Pancreatic Cancer Research Is Personal
Former Wisconsin Governor Tommy Thompson is an advocate for pancreatic cancer research because he lost both his brothers to the disease.
Helene Andrews-Polymenis, Ph.D., D.V.M.
A native of the Pacific Northwest, Dr. Helene Andrews-Polymenis earned an A.B. in Biology from Brown University (1989), Ph.D. in Molecular Biology/Microbiology from Tufts University (1999), and a D.V.M. from Texas A&M University (TAMU) in 2001. After completing her postdoctoral training, Dr. Andrews-Polymenis joined the faculty in the Department of Microbial and Molecular Pathogenesis at […]
mRNA Pancreatic Cancer Vaccine Trial Heading for Phase II
Dr. Vinod Balachandran provides the latest data on the mRNA pancreatic cancer vaccine, now headed to a phase II clinical trial.
Testing a New Immunotherapy Combo in Advanced Pancreatic Cancer
Researchers are testing an approved immunotherapy drug with a new drug that works on T cells to make it more effective for pancreatic cancer.
Novel Drug Combination Plus Radiation for Locally Advanced Pancreatic Cancer
A clinical trial combines immunotherapy, common treatments, an antiretroviral drug, and SBRT for locally advanced pancreatic cancer.
What Is a Clinical Trial?
A clinical trial is a type of research study that tests new drugs or drug combinations, procedures, or medical devices in patients with specific diseases or conditions. The goal of a clinical trial is to determine if a potential new treatment is safe and effective. Treatments that are tested in clinical trials have already been […]